{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T05:25:24Z","timestamp":1793856324422,"version":"4.6.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00415-026-14178-1","type":"journal-article","created":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T14:36:34Z","timestamp":1791124594000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cerebrospinal fluid inflammatory proteomic profiling identifies biomarkers linked to disease progression in amyotrophic lateral sclerosis"],"prefix":"10.1007","volume":"273","author":[{"given":"Congwen","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmei","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaye","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nairong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlong","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjiu","family":"Gou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianying","family":"Duo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0318-148X","authenticated-orcid":false,"given":"Yuwei","family":"Da","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,4]]},"reference":[{"issue":"5","key":"14178_CR1","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/S1474-4422(21)00465-8","volume":"21","author":"SA Goutman","year":"2022","unstructured":"Goutman SA, Hardiman O, Al-Chalabi A et al (2022) Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis. Lancet Neurol 21(5):480\u2013493. https:\/\/doi.org\/10.1016\/S1474-4422(21)00465-8","journal-title":"Lancet Neurol"},{"issue":"10","key":"14178_CR2","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/ene.14393","volume":"27","author":"P Masrori","year":"2020","unstructured":"Masrori P, Van Damme P (2020) Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol 27(10):1918\u20131929. https:\/\/doi.org\/10.1111\/ene.14393","journal-title":"Eur J Neurol"},{"issue":"10360","key":"14178_CR3","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","volume":"400","author":"EL Feldman","year":"2022","unstructured":"Feldman EL, Goutman SA, Petri S et al (2022) Amyotrophic lateral sclerosis. Lancet 400(10360):1363\u20131380. https:\/\/doi.org\/10.1016\/S0140-6736(22)01272-7","journal-title":"Lancet"},{"issue":"2","key":"14178_CR4","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/mus.26801","volume":"62","author":"NA Goyal","year":"2020","unstructured":"Goyal NA, Berry JD, Windebank A et al (2020) Addressing heterogeneity in amyotrophic lateral sclerosis clinical trials. Muscle Nerve 62(2):156\u2013166. https:\/\/doi.org\/10.1002\/mus.26801","journal-title":"Muscle Nerve"},{"issue":"3","key":"14178_CR5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41573-022-00612-2","volume":"22","author":"RJ Mead","year":"2023","unstructured":"Mead RJ, Shan N, Reiser HJ et al (2023) Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation. Nat Rev Drug Discov 22(3):185\u2013212. https:\/\/doi.org\/10.1038\/s41573-022-00612-2","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"14178_CR6","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1097\/WCO.0000000000000729","volume":"32","author":"A Chiot","year":"2019","unstructured":"Chiot A, Lobsiger CS, Boillee S (2019) New insights on the disease contribution of neuroinflammation in amyotrophic lateral sclerosis. Curr Opin Neurol 32(5):764\u2013770. https:\/\/doi.org\/10.1097\/WCO.0000000000000729","journal-title":"Curr Opin Neurol"},{"issue":"6","key":"14178_CR7","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1136\/jnnp-2015-310998","volume":"87","author":"J Labra","year":"2016","unstructured":"Labra J, Menon P, Byth K et al (2016) Rate of disease progression: a prognostic biomarker in ALS. J Neurol Neurosurg Psychiatry 87(6):628\u2013632. https:\/\/doi.org\/10.1136\/jnnp-2015-310998","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"14178_CR8","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1212\/01.wnl.0000194316.91908.8a","volume":"66","author":"F Kimura","year":"2006","unstructured":"Kimura F, Fujimura C, Ishida S et al (2006) Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology 66(2):265\u2013267. https:\/\/doi.org\/10.1212\/01.wnl.0000194316.91908.8a","journal-title":"Neurology"},{"issue":"24","key":"14178_CR9","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1212\/WNL.0000000000004029","volume":"88","author":"K Poesen","year":"2017","unstructured":"Poesen K, De Schaepdryver M, Stubendorff B et al (2017) Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease. Neurology 88(24):2302\u20132309. https:\/\/doi.org\/10.1212\/WNL.0000000000004029","journal-title":"Neurology"},{"issue":"7","key":"14178_CR10","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1093\/brain\/awaa098","volume":"143","author":"AR Gafson","year":"2020","unstructured":"Gafson AR, Barthelemy NR, Bomont P et al (2020) Neurofilaments: neurobiological foundations for biomarker applications. Brain 143(7):1975\u20131998. https:\/\/doi.org\/10.1093\/brain\/awaa098","journal-title":"Brain"},{"key":"14178_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10020354","author":"MA Leone","year":"2022","unstructured":"Leone MA, Mandrioli J, Russo S et al (2022) Neutrophils-to-lymphocyte ratio is associated with progression and overall survival in amyotrophic lateral sclerosis. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines10020354","journal-title":"Biomedicines"},{"issue":"1","key":"14178_CR12","doi-asserted-by":"publisher","first-page":"96","DOI":"10.14336\/AD.2023.0519","volume":"15","author":"D He","year":"2024","unstructured":"He D, Xu Y, Liu M et al (2024) The inflammatory puzzle: piecing together the links between neuroinflammation and amyotrophic lateral sclerosis. Aging Dis 15(1):96\u2013114. https:\/\/doi.org\/10.14336\/AD.2023.0519","journal-title":"Aging Dis"},{"issue":"1","key":"14178_CR13","doi-asserted-by":"publisher","first-page":"19796","DOI":"10.1038\/s41598-024-67165-9","volume":"14","author":"C Femiano","year":"2024","unstructured":"Femiano C, Bruno A, Gilio L et al (2024) Inflammatory signature in amyotrophic lateral sclerosis predicting disease progression. Sci Rep 14(1):19796. https:\/\/doi.org\/10.1038\/s41598-024-67165-9","journal-title":"Sci Rep"},{"key":"14178_CR14","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000697","author":"MN Olesen","year":"2020","unstructured":"Olesen MN, Wuolikainen A, Nilsson AC et al (2020) Inflammatory profiles relate to survival in subtypes of amyotrophic lateral sclerosis. Neurol Neuroimmunol Neuroinflamm. https:\/\/doi.org\/10.1212\/NXI.0000000000000697","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"14178_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2021.100168","volume":"20","author":"L Wik","year":"2021","unstructured":"Wik L, Nordberg N, Broberg J et al (2021) Proximity extension assay in combination with next-generation sequencing for high-throughput proteome-wide analysis. Mol Cell Proteom 20:100168. https:\/\/doi.org\/10.1016\/j.mcpro.2021.100168","journal-title":"Mol Cell Proteom"},{"issue":"10","key":"14178_CR16","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13955","volume":"22","author":"J Chen","year":"2023","unstructured":"Chen J, Doyle MF, Fang Y et al (2023) Peripheral inflammatory biomarkers are associated with cognitive function and dementia: Framingham heart study offspring cohort. Aging Cell 22(10):e13955. https:\/\/doi.org\/10.1111\/acel.13955","journal-title":"Aging Cell"},{"issue":"23","key":"14178_CR17","doi-asserted-by":"publisher","first-page":"12952","DOI":"10.1073\/pnas.1912839117","volume":"117","author":"J Huang","year":"2020","unstructured":"Huang J, Khademi M, Fugger L et al (2020) Inflammation-related plasma and CSF biomarkers for multiple sclerosis. Proc Natl Acad Sci USA 117(23):12952\u201312960. https:\/\/doi.org\/10.1073\/pnas.1912839117","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"14178_CR18","doi-asserted-by":"publisher","first-page":"e200132","DOI":"10.1212\/NXI.0000000000200132","volume":"10","author":"CC Pedersen","year":"2023","unstructured":"Pedersen CC, Ushakova A, Skogseth RE et al (2023) Inflammatory biomarkers in newly diagnosed patients with Parkinson disease and related neurodegenerative disorders. Neurol Neuroimmunol Neuroinflamm 10(4):e200132. https:\/\/doi.org\/10.1212\/NXI.0000000000200132","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"7","key":"14178_CR19","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1016\/j.clinph.2016.04.005","volume":"127","author":"N Geevasinga","year":"2016","unstructured":"Geevasinga N, Loy CT, Menon P et al (2016) Awaji criteria improves the diagnostic sensitivity in amyotrophic lateral sclerosis: a systematic review using individual patient data. Clin Neurophysiol 127(7):2684\u20132691. https:\/\/doi.org\/10.1016\/j.clinph.2016.04.005","journal-title":"Clin Neurophysiol"},{"issue":"1-2","key":"14178_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/s0022-510x(99)00210-5","volume":"169","author":"JM Cedarbaum","year":"1999","unstructured":"Cedarbaum JM, Stambler N, Malta E et al (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci 169(1\u20132):13\u201321. https:\/\/doi.org\/10.1016\/s0022-510x(99)00210-5","journal-title":"J Neurol Sci"},{"issue":"7","key":"14178_CR21","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1212\/01.wnl.0000243812.25517.87","volume":"67","author":"PH Gordon","year":"2006","unstructured":"Gordon PH, Cheung YK (2006) Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology 67(7):1314\u20131315. https:\/\/doi.org\/10.1212\/01.wnl.0000243812.25517.87","journal-title":"Neurology"},{"issue":"4","key":"14178_CR22","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/ana.27019","volume":"96","author":"J Zhang","year":"2024","unstructured":"Zhang J, Cao W, Xie J et al (2024) Metabolic syndrome and risk of amyotrophic lateral sclerosis: insights from a large-scale prospective study. Ann Neurol 96(4):788\u2013801. https:\/\/doi.org\/10.1002\/ana.27019","journal-title":"Ann Neurol"},{"issue":"6","key":"14178_CR23","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1002\/jcsm.13618","volume":"15","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Zhang Y, Li M et al (2024) Prognostic value of systemic inflammation, nutritional status and sarcopenia in patients with amyotrophic lateral sclerosis. J Cachexia Sarcopenia Muscle 15(6):2743\u20132755. https:\/\/doi.org\/10.1002\/jcsm.13618","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"14178_CR24","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1146\/annurev-statistics-022513-115638","volume":"1","author":"K Lange","year":"2014","unstructured":"Lange K, Papp JC, Sinsheimer JS et al (2014) Next generation statistical genetics: modeling, penalization, and optimization in high-dimensional data. Annu Rev Stat Appl 1(1):279\u2013300. https:\/\/doi.org\/10.1146\/annurev-statistics-022513-115638","journal-title":"Annu Rev Stat Appl"},{"issue":"1","key":"14178_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12987-024-00586-w","volume":"21","author":"S Sun","year":"2024","unstructured":"Sun S, Chen Y, Yun Y et al (2024) Elevated peripheral inflammation is associated with choroid plexus enlargement in independent sporadic amyotrophic lateral sclerosis cohorts. Fluids Barriers CNS 21(1):83. https:\/\/doi.org\/10.1186\/s12987-024-00586-w","journal-title":"Fluids Barriers CNS"},{"key":"14178_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2025.106933","volume":"211","author":"Y Chen","year":"2025","unstructured":"Chen Y, Sun S, Gao N et al (2025) Proximity extension assay reveals serum inflammatory biomarkers in two amyotrophic lateral sclerosis cohorts. Neurobiol Dis 211:106933. https:\/\/doi.org\/10.1016\/j.nbd.2025.106933","journal-title":"Neurobiol Dis"},{"issue":"10","key":"14178_CR27","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1038\/s41591-025-03890-6","volume":"31","author":"R Chia","year":"2025","unstructured":"Chia R, Moaddel R, Kwan JY et al (2025) A plasma proteomics-based candidate biomarker panel predictive of amyotrophic lateral sclerosis. Nat Med 31(10):3440\u20133450. https:\/\/doi.org\/10.1038\/s41591-025-03890-6","journal-title":"Nat Med"},{"key":"14178_CR28","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.bbrc.2022.04.127","volume":"613","author":"S Sjoqvist","year":"2022","unstructured":"Sjoqvist S, Otake K (2022) A pilot study using proximity extension assay of cerebrospinal fluid and its extracellular vesicles identifies novel amyotrophic lateral sclerosis biomarker candidates. Biochem Biophys Res Commun 613:166\u2013173. https:\/\/doi.org\/10.1016\/j.bbrc.2022.04.127","journal-title":"Biochem Biophys Res Commun"},{"issue":"1-2","key":"14178_CR29","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jneuroim.2010.03.004","volume":"222","author":"T Tateishi","year":"2010","unstructured":"Tateishi T, Yamasaki R, Tanaka M et al (2010) CSF chemokine alterations related to the clinical course of amyotrophic lateral sclerosis. J Neuroimmunol 222(1\u20132):76\u201381. https:\/\/doi.org\/10.1016\/j.jneuroim.2010.03.004","journal-title":"J Neuroimmunol"},{"issue":"6","key":"14178_CR30","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/j.1468-1331.2009.02560.x","volume":"16","author":"J Kuhle","year":"2009","unstructured":"Kuhle J, Lindberg RL, Regeniter A et al (2009) Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis. Eur J Neurol 16(6):771\u2013774. https:\/\/doi.org\/10.1111\/j.1468-1331.2009.02560.x","journal-title":"Eur J Neurol"},{"key":"14178_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21217923","author":"G Cipollina","year":"2020","unstructured":"Cipollina G, Davari Serej A, Di Nolfi G et al (2020) Heterogeneity of neuroinflammatory responses in amyotrophic lateral sclerosis: a challenge or an opportunity? Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21217923","journal-title":"Int J Mol Sci"},{"issue":"8","key":"14178_CR32","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.3390\/ijms22083875","volume":"22","author":"E Kallstig","year":"2021","unstructured":"Kallstig E, McCabe BD, Schneider BL (2021) The links between ALS and NF-kappaB. Int J Mol Sci 22(8):3875. https:\/\/doi.org\/10.3390\/ijms22083875","journal-title":"Int J Mol Sci"},{"issue":"16","key":"14178_CR33","doi-asserted-by":"publisher","first-page":"EMBJ201798697","DOI":"10.15252\/embj.201798697","volume":"37","author":"N Ouali Alami","year":"2018","unstructured":"Ouali Alami N, Schurr C, Olde Heuvel F et al (2018) NF-kappaB activation in astrocytes drives a stage-specific beneficial neuroimmunological response in ALS. EMBO J 37(16):EMBJ201798697. https:\/\/doi.org\/10.15252\/embj.201798697","journal-title":"EMBO J"},{"issue":"2","key":"14178_CR34","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaa124","volume":"2","author":"LC Beland","year":"2020","unstructured":"Beland LC, Markovinovic A, Jakovac H et al (2020) Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses. Brain Commun 2(2):fcaa124. https:\/\/doi.org\/10.1093\/braincomms\/fcaa124","journal-title":"Brain Commun"},{"key":"14178_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2019.100961","volume":"55","author":"Y Wang","year":"2019","unstructured":"Wang Y, Yang J, Hong T et al (2019) SIRT2: Controversy and multiple roles in disease and physiology. Ageing Res Rev 55:100961. https:\/\/doi.org\/10.1016\/j.arr.2019.100961","journal-title":"Ageing Res Rev"},{"issue":"3","key":"14178_CR36","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1159\/000338048","volume":"11","author":"S Korner","year":"2013","unstructured":"Korner S, Boselt S, Thau N et al (2013) Differential sirtuin expression patterns in amyotrophic lateral sclerosis (ALS) postmortem tissue: neuroprotective or neurotoxic properties of sirtuins in ALS? Neurodegener Dis 11(3):141\u2013152. https:\/\/doi.org\/10.1159\/000338048","journal-title":"Neurodegener Dis"},{"issue":"6","key":"14178_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.247","volume":"5","author":"C Valle","year":"2014","unstructured":"Valle C, Salvatori I, Gerbino V et al (2014) Tissue-specific deregulation of selected HDACs characterizes ALS progression in mouse models: pharmacological characterization of SIRT1 and SIRT2 pathways. Cell Death Dis 5(6):e1296. https:\/\/doi.org\/10.1038\/cddis.2014.247","journal-title":"Cell Death Dis"},{"issue":"3","key":"14178_CR38","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/path.5846","volume":"256","author":"P Banerjee","year":"2022","unstructured":"Banerjee P, Elliott E, Rifai OM et al (2022) NLRP3 inflammasome as a key molecular target underlying cognitive resilience in amyotrophic lateral sclerosis. J Pathol 256(3):262\u2013268. https:\/\/doi.org\/10.1002\/path.5846","journal-title":"J Pathol"},{"issue":"19","key":"14178_CR39","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1038\/emboj.2013.200","volume":"32","author":"TF Pais","year":"2013","unstructured":"Pais TF, Szego EM, Marques O et al (2013) The NAD-dependent deacetylase sirtuin 2 is a suppressor of microglial activation and brain inflammation. EMBO J 32(19):2603\u20132616. https:\/\/doi.org\/10.1038\/emboj.2013.200","journal-title":"EMBO J"},{"key":"14178_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1174180","volume":"14","author":"W Lu","year":"2023","unstructured":"Lu W, Ji H, Wu D (2023) SIRT2 plays complex roles in neuroinflammation neuroimmunology-associated disorders. Front Immunol 14:1174180. https:\/\/doi.org\/10.3389\/fimmu.2023.1174180","journal-title":"Front Immunol"},{"issue":"1","key":"14178_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116919","volume":"10","author":"X Chen","year":"2015","unstructured":"Chen X, Wales P, Quinti L et al (2015) The sirtuin-2 inhibitor AK7 is neuroprotective in models of Parkinson\u2019s disease but not amyotrophic lateral sclerosis and cerebral ischemia. PLoS ONE 10(1):e0116919. https:\/\/doi.org\/10.1371\/journal.pone.0116919","journal-title":"PLoS ONE"},{"key":"14178_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2019.172847","volume":"867","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Anoopkumar-Dukie S, Arora D et al (2020) Review of the anti-inflammatory effect of SIRT1 and SIRT2 modulators on neurodegenerative diseases. Eur J Pharmacol 867:172847. https:\/\/doi.org\/10.1016\/j.ejphar.2019.172847","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"14178_CR43","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/mus.70162","volume":"73","author":"J Zhu","year":"2026","unstructured":"Zhu J, Wen T, Gao N et al (2026) Elevated serum SIRT2 is associated with rapid progression and cognitive impairment in amyotrophic lateral sclerosis. Muscle Nerve 73(5):781\u2013787. https:\/\/doi.org\/10.1002\/mus.70162","journal-title":"Muscle Nerve"},{"key":"14178_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.117175","volume":"419","author":"JL Sanchez-Torres","year":"2020","unstructured":"Sanchez-Torres JL, Yescas-Gomez P, Torres-Romero J et al (2020) Matrix metalloproteinases deregulation in amyotrophic lateral sclerosis. J Neurol Sci 419:117175. https:\/\/doi.org\/10.1016\/j.jns.2020.117175","journal-title":"J Neurol Sci"},{"issue":"2","key":"14178_CR45","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1468-1331.2009.02775.x","volume":"17","author":"I Niebroj-Dobosz","year":"2010","unstructured":"Niebroj-Dobosz I, Janik P, Sokolowska B et al (2010) Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Eur J Neurol 17(2):226\u2013231. https:\/\/doi.org\/10.1111\/j.1468-1331.2009.02775.x","journal-title":"Eur J Neurol"},{"key":"14178_CR46","unstructured":"Sokolowska B, Jozwik A, Niebroj-Dobosz I et al (2009) Evaluation of matrix metalloproteinases in serum of patients with amyotrophic lateral sclerosis with pattern recognition methods. J Physiol Pharmacol, 60(Suppl 5):117\u2013120. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20134051"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-14178-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-14178-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-14178-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:45:51Z","timestamp":1793853951000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-14178-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":46,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["14178"],"URL":"https:\/\/doi.org\/10.1007\/s00415-026-14178-1","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"30 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there is no conflict of interest.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Xuanwu Hospital of the Capital Medical University, in accordance with the Declaration of Helsinki guidelines.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participants prior to their inclusion in the study. All participants provided consent for both their participation and the publication of anonymized results.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"638"}}